1 / 15

The gut microbiota shapes intestinal immune response during health and disease

February 15 th 2010. The gut microbiota shapes intestinal immune response during health and disease. Round and Mazmanian, Nature Reviews Immunology, Vol.9 2009. Gut microbiota. more than 1000 species collective weight of about 1kg in human intestine

tamarr
Télécharger la présentation

The gut microbiota shapes intestinal immune response during health and disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. February 15th 2010 The gut microbiota shapes intestinal immune response during health and disease Round and Mazmanian, Nature Reviews Immunology, Vol.9 2009

  2. Gut microbiota • more than 1000 species • collective weight of about 1kg in human intestine • colonization begins immediately after birth • symbiotic bacteria provide benefits to the host: • nutrient supply • pathogen defense • immune system development/ function O´Hara and Shanahan, EMBO reports, 2006

  3. GALT Peyer`s patches appendix isolated lymphoid follicles Gut-associated lymphoid tissue (GALT) intestinal epithelial cell (IEC) = T-cell areas = B-cell follicles

  4. Developmental defects in germ-free mice • IEC show decreased rates of cell-turnover and reduced expression of MHC class II molecules, TLR9 and antimicrobial proteins • fewer lymphocytes in lamina propria and epithelium • fewer and smaller Peyer`s patches, isolated lymphoid follicles and mesenteric lymph nodes • reduced levels of secretory IgA Macpherson and Harris, Nat rev Immunol., 2004

  5. Defects in immune response in germ-free mice • decreased immune resistance to infection with Shigella flexneri • decreased bacterial clearence upon Listeria monocytogenes infection • Salmonella enterica serovar Typhimurium exploits deficiency in colonization resistance to establish infection

  6. Inflammatory bowel disease (IBD) • chronic inflammation of the gastointestinal tract • two main forms: 1. Crohn`s disease • affects all layers of the bowel wall • granuloma formation in up to 60% of patients 2. Ulcerative colitis • affects superficial mucosal layers • no pathogen has been conclusively shown to be the causative agent • incidence is the highest in developed countries Crohn´s disease Janeway, Immunobiology, 7ed.

  7. mucosal homeostasis  cytokine production by regulatory (TReg) T cells supresses pro-inflammatory responses IBD is driven by T cells TH1, TH2, TH17 TReg mucosal inflammation  increased production of pro-inflammatory cytokines by T helper (TH) cells TNF, IFNγ, IL-17  TReg transfer can prevent the induction of experimental colitis adapted from Bouma and Strober, Nat rev Immunol., 2003 and Vignali et al., Nat rev Immunol., 2008

  8. germ-free animals show defective TH17 cell development in the small intestine ATP generated by intestinal bacteria increases the production of IL-17 in the colon germ-free mice have reduced numbers of TReg cells in the mesenteric lymph nodes increased numbers of Treg cells in the small intestine of germ-free mice Involvement of the microbiota in regulating the balance between TH and TReg cell subsets in the gut TReg TH  Intestinal bacteria direct the differentiation of both pro- and anti-inflammatory T cell populations and may therefore play a crucial role in IBD

  9. Evidence for the involvement of commensal bacteria in IBD • IBD patients have increased antibody titres against indigenous bacteria • inflammatory lesions are pronounced in areas with high numbers of bacteria • genetic variants that are highly linked to IBD include mutations in genes that are involved in bacterial sensing (NOD2) and T cell immunity (IL23R) • IBD patients show abnormal microbial composition (= dysbiosis) • mice studies showed that dysbiosis alone may be important for the induction of IBD

  10. Immunological dysregulation associated with dysbiosis of the microbiota • Symbionts • health promoting functions Commensals • provide no benefit or detriment Pathobionts  have the potential to induce pathology  Inflammatory responses in IBD are directed towards pathobionts

  11. Different bacterial species ameliorate the symptoms of IBD Probiotics • dietary microorgansims that are beneficial to the health of the host • act on serveral cell types (epithelial cells, DCs, T cells) • ability to limit inflammation by induction of TReg cells VSL#3: mixture of Lactobacillus spp., Bifidobacterium spp., Streptococcus salivarius

  12. Model for Bacteroides fragilis-mediated protection from disease induced by Heliobacter hepaticus PSA: polysaccharid A (= symbiotic factor)  symbiotic factors actively maintain health

  13. Proposed causes of dysbiosis of the microbiota  Increased incidence of immune-mediated disorders in developed countries could be due to alterations in the microbiota

  14. Summary • the microbiota promote the appropriate development of the immune system • immune-mediated disorders seem to involve reduced TReg cell activity • absence of beneficial microorganisms (owing to dysbiosis) can lead to the induction of inflammatory responses and immune-mediated diseases  the microbiota plays an important role in supporting health

  15. Thank you for your attention!

More Related